Background
Aim
To systematically review studies that have examined the association between point-of-care (POC) C-reactive protein testing and antibiotic prescribing for RTIs in general practice.
Design and setting
Systematic review and meta-analysis of randomised controlled trials and observational studies.
Method

MEDLINE
® and Embase were systematically searched to identify relevant publications. All studies that examined the association between POC C-reactive protein testing and antibiotic prescribing for patients with RTIs were included. Two authors independently screened the search results and extracted data from eligible studies. Dichotomous measures of outcomes were combined using risk ratios (RRs) with 95% confidence intervals (CIs) either by fixed or random-effect models.
Results
Thirteen studies containing 10 005 patients met the inclusion criteria. POC C-reactive protein testing was associated with a significant reduction in antibiotic prescribing at the index consultation (RR 0.75, 95% CI = 0.67 to 0.83), but was not associated with antibiotic prescribing at any time during the 28-day follow-up period (RR 0.85, 95% CI = 0.70 to 1.01) or with patient satisfaction (RR 1.07, 95% CI = 0.98 to 1.17).
INTRODUCTION
Respiratory tract infections (RTIs) are among the most common acute conditions leading to patients seeking consultations in general practice. 1 About 80% of patients with RTIs are prescribed antibiotics. 2 However, RTIs are most often self-limiting and seldom require antibiotics for treatment. 3 The increased use of antibiotics is significantly associated with the development of drugresistant bacteria. Clinical guidelines do not support routine antibiotic treatment for patients with RTIs. 4 Diagnostic uncertainty often leads to increased inappropriate antibiotic prescribing. 5, 6 C-reactive protein (CRP) is an acknowledged biomarker to diagnose bacterial infection. The level of CRP can be measured by point-of-care (POC) testing, which is easy to perform in general practice. The robustness and accuracy of POC CRP testing have been proved by many diagnostic studies. [7] [8] [9] POC CRP testing plays an important role in decreasing diagnostic uncertainty and guiding antibiotic treatment decisions.
To examine the impact of CRP measurement on antibiotic prescribing in patients with RTIs, many randomised controlled trials (RCTs) and observational studies have been conducted. [10] [11] [12] [13] However, they did not reach consistent conclusions. For example, Bjerrum et al 10 and Cals et al 13 concluded that POC CRP testing significantly reduced antibiotic prescribing for patients with RTIs. However, Gonzales et al 11 found there was no difference in antibiotic prescribing between POC CRP tested and control patients. In addition, these studies had small sample sizes and thus lacked a more convincing statistical power to clarify whether the use of POC CRP testing in general practice can reduce antibiotic prescribing.
This article describes a systematic review and meta-analysis that were conducted to study the association between family physician use of POC CRP testing and antibiotic prescribing for RTIs in general practice.
METHOD Eligibility
Studies were included that examined patients who had been diagnosed with RTIs; and compared the antibiotic prescribing rate of a POC CRP testing group with a no-POC CRP testing group. Studies were included if they were RCTs (including parallel-group RCTs, cluster RCTs, crossover RCTs, and factorial RCTs) or observational studies.
Literature search
Literature searches were conducted on 6 June 2013 using the electronic databases MEDLINE ® (1946 to present) and Embase (1980 to present). Appendix 1 shows the search terms used.
Selection of studies
Two authors independently evaluated the articles for inclusion. Any discrepancies were resolved by further discussion and consultation from a third author. The selection process by means of a flow chart is presented in Figure 1 .
Data extraction
A standardised data extraction form was used. The following information was extracted: first author name, publication year, setting, study design, age, sex, location of RTIs, sample size (POC CRP testing/ no-POC CRP testing) ( Table 1 ). The primary outcome of interest was antibiotic prescribing at the index consultation, which was defined as those patients using antibiotics immediately and those filling a delayed prescription. 13 The secondary outcomes were antibiotic prescribing at any time during the 28-day follow-up period and patient satisfaction.
Assessment of risk of bias
The risk of bias for the included RCTs and observational studies was assessed using the Cochrane Collaboration's tool for assessing risk of bias 14 and the NewcastleOttawa scale, 15 respectively. Two authors independently assessed the methodological quality of studies. Any discrepancies were resolved by a third author.
Statistical analysis
Heterogeneity was quantified by means of I 2 , with a predefined significance threshold of 40%. 16 If a significant trend for heterogeneity was observed, a random effect model via generic inverse variance weighting was used to combine the effect. Otherwise, a fixed-effects model was used to calculate the pooled effects. 17 Results were expressed as relative risk (RR) with 95% confidence intervals (CIs) for dichotomous variables. Results were considered statistically significant when P <0.05. Revman software (version 5.2) was used. This software was available through the Cochrane Collaboration.
Subgroup analyses were carried out for the primary outcome with study design (parallel-group RCTs, cluster RCTs and observational studies) and location of RTIs (upper RTIs and lower RTIs). Sensitivity analyses were also performed for the primary outcome to restrict the analyses to European studies and to restrict the analyses to English language studies. No protocol of the present review has been published or registered.
RESULTS
Literature search
A total of 2529 citations were identified. After excluding 602 duplicate records, two authors screened 1927 titles and abstracts to identify the potentially relevant studies. In total 37 fulltext articles were assessed for eligibility. Of these, 13 studies were included in qualitative synthesis, [10] [11] [12] [13] [18] [19] [20] [21] [22] [23] [24] [25] [26] and subsequently all
How this fits in
This study is the first to investigate the relationship between point-of-care C-reactive protein testing and antibiotic prescribing for respiratory tract infections.
The results indicate that point-of-care C-reactive protein testing significantly reduces antibiotic prescribing for patients with respiratory tract infections.
British 13 studies met the final eligibility criteria for meta-analysis. The detailed selection process is outlined in Figure 1 .
Description of studies
There were 13 studies with a total of 10 005 patients with RTIs, [10] [11] [12] [13] [18] [19] [20] [21] [22] [23] [24] [25] [26] which studied the association between POC CRP testing and antibiotic prescribing. Of the 13 included studies, four studies were conducted in the Netherlands, 13, [19] [20] [21] three in Norway, 18, 22, 26 two in Denmark, 10, 25 two in Spain, 12, 23 one in Ireland, 24 and one in the US. 11 Four studies were parallel-group RCTs. 11, 13, 25, 26 Three studies were cluster RCTs. [19] [20] [21] Six studies were observational studies. 10, 12, 18, [22] [23] [24] Table  1 summarises the basic characteristics of the included studies.
Assessment of risk of bias
Complete risk of bias assessment was performed for all studies. The six observational studies were scored using the Newcastle-Ottawa scale:
10,12,18,22-24 four studies got six stars, 12, 18, 23, 24 and two studies got seven stars 10, 22 (Table 1) . Results of the assessment for the seven RCTs (four parallel-group RCTs and three cluster RCTs) are shown in Table 2 .
Antibiotic prescribing at the index consultation All the 13 studies provided information on antibiotic prescribing at the index consultation to calculate the overall effect size. [10] [11] [12] [13] [18] [19] [20] [21] [22] [23] [24] [25] [26] Twelve of these studies reported a decreased antibiotic prescribing Pooling of the mean proportion showed that 43.6% of patients with RTIs in the POC CRP testing group and 62.5% of patients with RTIs in the no-POC CRP testing group were prescribed antibiotics. The meta-analysis showed that POC CRP testing was associated with a significant reduction in antibiotic prescribing at the index consultation (RR 0.75, 95% CI = 0.67 to 0.83; P<0.001 for heterogeneity; I 2 = 76%) ( Figure 2 ). effect size. 13, 20, 21, 24, 25 Four of these studies showed a decreased antibiotic prescribing rate in the POC CRP testing group. 13, 20, 21, 24 Two of them were significant. 20, 21 Pooling of the mean proportion showed that 32.1% of patients in the POC CRP testing group and 37.9% of patients in the no-POC CRP testing group were prescribed antibiotics. The meta-analysis showed a non-significant effect on antibiotic prescribing at any time during the 28-day follow-up period (RR 0.85, 95% CI = 0.70 to 1.01; P = 0.06 for heterogeneity; I 2 = 56%) ( Figure 3A) .
Antibiotic prescribing at any time during the 28-day follow-up period
Patient satisfaction
Three studies reported patient satisfaction, with 794 patients. 13, 20, 24 Two of these studies reported increased patient satisfaction in the POC CRP testing group. 13, 20 One of them was significant. 13 The combined results indicated a non-significant increase of patient satisfaction in the POC CRP testing group (RR 1.07, 95% CI = 0.98 to 1.17; P = 0.24 for heterogeneity; I 2 = 30%) ( Figure  3B ).
Subgroup analyses
Subgroup analyses were performed for the primary outcome according to study design (parallel-group RCTs, cluster RCTs and observational studies) and location of RTIs (upper RTIs and lower RTIs). In the subgroup of cluster RCTs, observational studies, patients with upper RTIs and lower RTIs, the overall results all showed significant reductions of antibiotic prescribing in the POC CRP testing group. In the subgroup of parallel-group RCTs, the overall result demonstrated a non-significant reduction of antibiotic prescribing in the POC CRP testing group (Table 3) .
Sensitivity analysis
To test the robustness of the results, the analyses were restricted to the 12 European studies 10, 12, 13, [18] [19] [20] [21] [22] [23] [24] [25] [26] and to the English language studies. [10] [11] [12] [13] [19] [20] [21] [22] [23] [24] [25] Pooled data from the European studies and pooled data from the English language studies continued to demonstrate a significant reduction of antibiotic prescribing in the POC CRP testing group (Table 3) .
DISCUSSION Summary
This meta-analysis comprehensively summarised the current evidence from 13 studies on the association between POC CRP testing and antibiotic prescribing for RTIs in general practice. POC CRP testing was found to significantly decrease antibiotic prescribing at the index consultation. Although there was significant heterogeneity in the meta-analysis, results from the sensitivity analysis were consistent, which strengthened the robustness of the conclusion.
Strengths and limitations
Patients with upper RTIs and patients with lower RTIs were included in the analysis. The meta-analysis of primary outcome included 13 eligible studies. A previous systematic review that studied the association between POC CRP testing and antibiotic prescribing only included patients with lower RTIs and identified five studies. 27 Comprehensive search strategies were performed to identify relevant studies. The search was not restricted to English language articles. Two grey literature articles 18, 26 were identified from non-English language journals and were included in the analyses.
Due to limitations of time, money and human resources, the meta-analysis was based on aggregated data extracted from the published full-text articles, rather than individual patient data requested from the researchers of the eligible studies. Meta-analysis that is merely based on aggregated level data has limitations in conducting subgroup analyses. 28 It is not always possible to explore the sources of heterogeneity. 29 In this study, significant heterogeneity was identified. Although subgroup analyses were conducted according to location of the RTIs and study design, the heterogeneity still existed within subgroups of upper RTIs, lower RTIs, and subgroups of observational studies. Future research needs to collect original data and conduct individual patient meta-analyses to find more potential reasons for the heterogeneity. 
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Comparison with existing literature
To the authors knowledge, this is the first meta-analysis that aims to summarise all the research evidence that has studied the association between POC CRP testing and antibiotic prescribing in patients with RTIs. A systematic review conducted by Engel et al 27 concentrated on patients with lower RTIs only. They included both randomised and observational studies. Their results showed that POC CRP testing was associated with a significant reduction in antibiotic prescribing (RR 0.6, 95% CI = 0.5 to 0.7). It is consistent with the subgroup result of lower RTIs in the current study.
Implications for research and practice
For each patient with a RTI, family physicians have to decide whether to prescribe antibiotics for them. POC CRP testing can facilitate RTI consultation and decision making in general practice. If POC CRP is tested and the test result shows that the CRP level is low, it is most likely that the family physician will not prescribe antibiotics for this patient.
Family physicians should be aware of the problems that arise from over-prescription of antibiotics, which may drive antibiotic resistance. Reduced antibiotic prescribing in general practice is associated with reduced local antibiotic resistance. 30 The POC CRP test is an office-based and costeffective test. 19, 31 There are few limitations for its applicability in general practice. This study has indicated that POC CRP testing in general practice is associated with significant reductions in antibiotic prescribing at the index consultation for patients with RTIs. Further individual patient data meta-analyses and studies with large sample sizes are needed to investigate the potential confounders that lead to the heterogeneity.
